DB16659InvestigationalProtein Based Therapies
Bentracimab is under investigation in clinical trial NCT04286438 (Bentracimab (PB2452) in Ticagrelor-treated Patients With Uncontrolled Major or Life-threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure).
- Code names
- MEDI-2452 · PB-2452
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Bentracimab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account